MDGL vs. AVGO
MDGL (Madrigal Pharmaceuticals, Inc.) and AVGO (Broadcom Inc.) are both stocks. MDGL operates in Biotechnology (Healthcare), while AVGO operates in Semiconductors (Technology). Over the past 10 years, MDGL returned 46.09%/yr vs 40.96%/yr for AVGO. At a 0.24 correlation, their price movements are largely independent.
Performance
MDGL vs. AVGO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MDGL achieves a -17.44% return, which is significantly lower than AVGO's 10.62% return. Over the past 10 years, MDGL has outperformed AVGO with an annualized return of 46.09%, while AVGO has yielded a comparatively lower 40.96% annualized return.
MDGL
- 1D
- 1.37%
- 1M
- -10.95%
- YTD
- -17.44%
- 6M
- -15.87%
- 1Y
- 62.66%
- 3Y*
- 21.44%
- 5Y*
- 34.82%
- 10Y*
- 46.09%
AVGO
- 1D
- -0.91%
- 1M
- -10.14%
- YTD
- 10.62%
- 6M
- 6.58%
- 1Y
- 54.87%
- 3Y*
- 67.17%
- 5Y*
- 55.09%
- 10Y*
- 40.96%
MDGL vs. AVGO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
MDGL Madrigal Pharmaceuticals, Inc. | -17.44% | 88.72% | 33.36% | -20.28% | 242.52% | -23.77% | 22.02% | -19.17% | 22.80% | 516.04% |
AVGO Broadcom Inc. | 10.62% | 50.63% | 110.49% | 104.18% | -13.27% | 56.48% | 44.88% | 29.05% | 2.18% | 48.19% |
Correlation
The correlation between MDGL and AVGO is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.14 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.22 |
Correlation (All Time) Calculated using the full available price history since Aug 6, 2009 | 0.24 |
The correlation between MDGL and AVGO shifts across timeframes, from 0.07 (1 year) to 0.24 (all time), reflecting how their relationship changes across market environments.
Fundamentals
MDGL:
$13.96B
AVGO:
$1.86T
MDGL:
-$12.87
AVGO:
$6.01
MDGL:
10.21
AVGO:
24.70
MDGL:
25.68
AVGO:
21.24
MDGL:
$1.13B
AVGO:
$75.47B
MDGL:
$1.05B
AVGO:
$50.53B
MDGL:
-$287.63M
AVGO:
$41.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MDGL vs. AVGO — Risk / Return Rank
MDGL
AVGO
MDGL vs. AVGO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Madrigal Pharmaceuticals, Inc. (MDGL) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MDGL | AVGO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.24 | ||
| Sortino ratioReturn per unit of downside risk | +0.51 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.22 | +0.04 |
| Calmar ratioReturn relative to maximum drawdown | 2.11 | 1.77 | +0.35 |
| Martin ratioReturn relative to average drawdown | 4.63 | 4.11 | +0.52 |
Loading charts...
Drawdowns
MDGL vs. AVGO - Drawdown Comparison
The maximum MDGL drawdown since its inception was -98.40%, which is greater than AVGO's maximum drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for MDGL and AVGO.
Loading charts...
Drawdown Indicators
| MDGL | AVGO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.40% | -48.30% | -50.10% |
Max Drawdown (1Y)Largest decline over 1 year | -29.36% | -28.67% | -0.69% |
Max Drawdown (3Y)Largest decline over 3 years | -52.88% | -41.15% | -11.73% |
Max Drawdown (5Y)Largest decline over 5 years | -61.41% | -41.15% | -20.26% |
Max Drawdown (10Y)Largest decline over 10 years | -82.19% | -48.30% | -33.89% |
Current DrawdownCurrent decline from peak | -20.25% | -20.66% | +0.41% |
Average DrawdownAverage peak-to-trough decline | -58.52% | -7.98% | -50.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.38% | 12.30% | +1.08% |
Volatility
MDGL vs. AVGO - Volatility Comparison
The current volatility for Madrigal Pharmaceuticals, Inc. (MDGL) is 13.71%, while Broadcom Inc. (AVGO) has a volatility of 20.53%. This indicates that MDGL experiences smaller price fluctuations and is considered to be less risky than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MDGL | AVGO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.71% | 20.53% | -6.82% |
Volatility (6M)Calculated over the trailing 6-month period | 31.76% | 35.04% | -3.28% |
Volatility (1Y)Calculated over the trailing 1-year period | 45.97% | 45.57% | +0.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 133.37% | 43.39% | +89.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 117.49% | 39.52% | +77.97% |
Dividends
MDGL vs. AVGO - Dividend Comparison
MDGL has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.65%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AVGO Broadcom Inc. | 0.65% | 0.70% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 3.11% | 1.87% | 1.43% | 1.13% |
MDGL Madrigal Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
MDGL vs. AVGO - Financials Comparison
This section allows you to compare key financial metrics between Madrigal Pharmaceuticals, Inc. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MDGL vs. AVGO - Profitability Comparison
MDGL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Madrigal Pharmaceuticals, Inc. reported a gross profit of 284.49M and revenue of 311.34M. Therefore, the gross margin over that period was 91.4%.
AVGO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported a gross profit of 14.92B and revenue of 22.19B. Therefore, the gross margin over that period was 67.2%.
MDGL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Madrigal Pharmaceuticals, Inc. reported an operating income of -92.72M and revenue of 311.34M, resulting in an operating margin of -29.8%.
AVGO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported an operating income of 10.87B and revenue of 22.19B, resulting in an operating margin of 49.0%.
MDGL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Madrigal Pharmaceuticals, Inc. reported a net income of -94.39M and revenue of 311.34M, resulting in a net margin of -30.3%.
AVGO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Broadcom Inc. reported a net income of 9.31B and revenue of 22.19B, resulting in a net margin of 42.0%.
Frequently Asked Questions
MDGL and AVGO have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AVGO has higher volatility (20.53%) compared to MDGL (13.71%). In terms of maximum drawdown, MDGL dropped -98.40% vs AVGO's -48.30%.
MDGL currently has the higher Sharpe Ratio (1.35 vs 1.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MDGL and AVGO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer